Voices
Hidehito Horinouchi: Lung Cancer Brain Metastases At The Dawn Of Personalized Medicine
Hidehito Horinouchi/X

Hidehito Horinouchi: Lung Cancer Brain Metastases At The Dawn Of Personalized Medicine

Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:

“Lung cancer brain mets at the dawn of personalized medicine.

Emerging systemic therapies show growing intracranial efficacy Dr. Antoine Mavrikios, Corinne Faivre-Finn.”Hidehito Horinouchi: Lung Cancer Brain Metastases At The Dawn Of Personalized Medicine

Title: Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?

Authors: A. Mavrikios, M. Bortolot, C. Le Péchoux, J. Remon, A. Botticella, M. Aldea, P.D. Brown, C.G. Rusthoven, P. Lavaud, M. Frelaut, P. Abdayem, D. Lavigne, A. Camps-Malea, B. Besse, D. Planchard, F. Barlesi, J. Jacob, P. Gougis, S. Knafo, C. Chargari, F. Dhermain, E. Deutsch, C. Faivre-Finn, A. Levy
Read the Full Article.

Hidehito Horinouchi: Lung Cancer Brain Metastases At The Dawn Of Personalized Medicine

A. Botticella A. Camps-Malea A. Levy A. Mavrikios Antoine Mavrikio Antoine Mavrikios B. Besse C. Chargari C. Faivre-Finn C. Le Péchoux C.G. Rusthoven cancer Corinne Faivre-Finn D. Lavigne D. Planchard E. Deutsch F. Barlesi F. Dhermain Hidehito Horinouchi J. Jacob J. Remon Lung cancer M. Aldea M. Bortolot M. Frelaut OncoDaily Oncology P. Abdayem P. Gougis P. Lavaud P.D. Brown S. Knafo